Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nektar Therapeutics (NASDAQ: NKTR).

Full DD Report for NKTR

You must become a subscriber to view this report.


Recent News from (NASDAQ: NKTR)

An Early Look At Nektar And Bristol-Myers Squibb's First Combination Phase 3 Trial
Introduction In the middle of August, Nektar Therapeutics ( NKTR ) and Bristol-Myers Squibb ( BMY ) revealed the outline of their phase 3 trial on clinicaltrial.gov . This represents the first phase 3 trial following the lucrative global strategic development and commercialization collab...
Source: SeekingAlpha
Date: September, 11 2018 10:46
Healthcare And Biotechnology Dashboard - Update
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology is undervalued regarding historical averages in 2 out of 3 valuation me...
Source: SeekingAlpha
Date: September, 10 2018 20:42
Senate vote approaches on bill to combat opioid crisis
The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news...
Source: SeekingAlpha
Date: September, 07 2018 12:48
Today's Research Reports on Trending Tickers: Cronos Group and Nektar Therapeutics
NEW YORK, NY / ACCESSWIRE / September 5, 2018 / Wall Street finished in the red on Tuesday as investors focused on the latest trade negotiations between the U.S. and Canada, potentially paving the way to a revised North American Free Trade Agreement. The Dow Jones Industrial Average was dow...
Source: ACCESSWIRE IA
Date: September, 05 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1463.0961.9063.7860.692,146,634
2017-02-0312.5312.49512.6312.42208,176
2017-02-0212.4512.3912.53512.161,078,457
2017-02-0112.1212.6312.6312.051,405,769
2017-01-3111.6512.1112.1411.411,589,827

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-07251,679458,99954.8321Short
2018-12-06277,907713,88038.9291Short
2018-12-04222,279481,45646.1681Short
2018-12-03222,657498,48044.6672Short
2018-11-30214,264376,47356.9135Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NKTR.


About Nektar Therapeutics (NASDAQ: NKTR)

Logo for Nektar Therapeutics (NASDAQ: NKTR)

Not available

 

Contact Information

 

 

Current Management

  • Ajit S. Gill / President, CEO
  • Ajay Bansal / CFO

Current Share Structure

  • Market Cap: $14,620,631,203 - 05/18/2018
  • Issue and Outstanding: 171,402,476 - 05/03/2018

 


Recent Filings from (NASDAQ: NKTR)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: July, 10 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: June, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 04 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 22 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018

 

 


Daily Technical Chart for (NASDAQ: NKTR)

Daily Technical Chart for (NASDAQ: NKTR)


Stay tuned for daily updates and more on (NASDAQ: NKTR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NKTR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NKTR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NKTR and does not buy, sell, or trade any shares of NKTR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/